Drugs / DNR.NPC-specific T cells
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT02065362 | Feb 2015 → Mar 2017 overdue | nasopharyngeal carcinoma | Baylor College of Medicine | Active not recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DNR.NPC-specific T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02065362 ↗ |
| Route | Intravenous | “The T cells will be thawed and infused through a central line, or through a vein in the patient's arm over 1 to 10 minutes.” NCT02065362 ↗ |